GALWAY, IRELAND--January 15, 2025--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--MSD Ireland (Dublin, Ireland), part of Merck & Co. (NYSE:MRK) (Rathway, New Jersey), is spending 500 million euro (US$521 million) to acquire WuXi Biologics' (Jiansu, China) Dundalk vaccines manufacturing site as part of an ongoing expansion of its Irish operations. Within this article: Details purchase of WuXi's Dundalk vaccines plant, expansion of MSD's Irish operations, key projects
(All Fields Required)
Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.
×For More Info!
